ClinicalTrials.Veeva

Menu

Apoptosis May Have a Role in Etiopathogenesis of Obstetric Cholestasis.

Z

Zekai Tahir Burak Women's Health Research and Education Hospital

Status

Unknown

Conditions

Pregnancy

Study type

Observational

Funder types

Other

Identifiers

NCT02192177
M30 Intrahepatic cholestasis

Details and patient eligibility

About

Intrahepatic cholestasis of pregnancy is a disease specific to pregnancy period; especially late second and third trimester. We aimed to investigate the role of apoptosis in etiopathogenesis of obstetric cholestasis.

Full description

M30 (caspases cleaved Cytokeratin-18 (CK-18) fragment) is a specific apoptosis marker. We aimed to use it to evaluate the apoptotic process.

Enrollment

50 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Late second or third trimester of pregnancy.

Exclusion criteria

  • Foreknown systemic diseases, multiple pregnancy, smoking cigarettes.

Trial design

50 participants in 2 patient groups

Group 1
Description:
Pregnant subjects diagnosed with obstetric cholestasis who didn't have any foreknown systemic disease.
Group 2
Description:
entirely healthy pregnant subjects, the control group.

Trial contacts and locations

1

Loading...

Central trial contact

Ali O Ersoy

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems